| Tag | Content |
|---|
EnhancerAtlas ID | HS113-23587 |
Organism | Homo sapiens |
Tissue/cell | Keratinocyte |
Coordinate | chr22:26811820-26813850 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOSL1 | MA0477.1 | chr22:26813074-26813085 | GGTGACTCATG | + | 6.62 | | FOSL2 | MA0478.1 | chr22:26813073-26813084 | GGGTGACTCAT | + | 6.14 | | JUNB | MA0490.1 | chr22:26813073-26813084 | GGGTGACTCAT | + | 6.32 | | JUND | MA0491.1 | chr22:26813074-26813085 | GGTGACTCATG | + | 6.02 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH22I026416 | chr22 | 26812481 | 26813547 |
|
Enhancer Sequence | CAACCTAGCG GAAGGTTTGA TGAGGGCACT GTGTTGCCCG GGTCAAGGGA GCTACAAGGG 60
GTAATGAAAG CTGTGAGTAA CAATACAGTT GTTCATGTTC ATGCTAACTC TTCTTGTGGT 120
CAAGCAAGAT CCTGGAGTCA GTAGCTTGAA TAAAAATGGT TAAAATGTGT GTGCTTTGGT 180
GGATAAGGAG GCTGAGGACA GGAGAAAACT AAAAGTTGTT GGGTACTCCT AAGTCAGACT 240
GTGTGTAAGT GGTTTGCTTA TATTATCTTA TTTGATTGCT ATGACAATAC TCTGAGGTTG 300
GTAATAAGCC CATTGTTACA GATGGACAAC TGAGGCTCTG AGAGCTTCAG TAACCCGTGT 360
CTAAGGCTGC ATAGCCAATG ATGGGTAAAA CGGGGATTCA AACCTACATT TGAGCCTAAA 420
GCTCCTTGTT TTCTTCCACC AGGTGAAGTA AGAGTTTGTA AAGGCAAAAA TTCTGAACAG 480
TGCCTCCTAG GTTAACAGAA ATCATGATGA CTTTGCCAGC AAAAGACTCG GAGGAACATT 540
GAGTACACAG CCTCTCAGTT CTAGGTAGGT CATATGTGTC AGCCAGTAGG TTGAGTTTAT 600
AACAGTCACG TCGTGACCTG AACACCCTCC CACTCCACTG CTGAATCAAC TAGATAGAAT 660
CTGGCAGGGA TGATATATAA CTACCTTAGA CAGGTGTAAG GGAGGGGAAA ATACAGACAA 720
AAAGACAACA AAAAGGAAGC TTGCAAGAAA AACGAAAAAA ACTGAACTAA CCCCTAATGC 780
ATCTGATTGA GGCTTCTGCA AAACTACCAG ATGCATTCAG ATCAAACTAA CTATTAAGAA 840
ATGCAAAGAA TTGGATGCTG TCTTAGGTTG AAACAAATCA AAACAAAAAA GAAATGCAAA 900
GAAAACTTAG CTCCTTGGAG CTGTCCTAAA TTCATATACC ATGCTTGAGC TTGTAACATT 960
GATCCAGGTG ACTCCCAGTT ACGGTGTTCA CTTTGTTCCC TCTAGGTATG TGCCAGGTGA 1020
TGAGGAGACA TACTGTCTGG GCTCTTCAGA CAGGCTTCTT TCTCCCTGGA ACTCAGAAAA 1080
TTCCAACTAC CTAGAGTTTG CAAAGGCAGC CGGCCAGGGA AGGATGCTGG CTCCAGGTCC 1140
TGGGGCCCCT CCCTGGAGGG AACAAATGCC TCTCGGATTG CAGCTGCAGA AAGAGAGAGG 1200
AGAATCGGGG AATGGAATGG TGTGCTGCAG AGGCAGTGGT TTGGACAGCG ACTGGGTGAC 1260
TCATGCCCCA GGCAGCTTTT TACAGGAGTT GCAAATTCCA GTAATAGCAG ATCAGGAACA 1320
TCTCTCGAGG GACACCCTAC CAATCGAAGG TGTCTCTTGC ACCATCTTGG CAGCGCTGAA 1380
TGGGCATCTG AATAGCTTAT CTATTCAGAT CCTTTGCCGG ATCCCAAAGG TTCTCCTTGC 1440
TTTGGCCCCT GGGCTTCCTG AAACCGGGCG GTTATTCTCC CCGGAAGTTG GAGGAATTGG 1500
ATAATATTGT CTACAGACAC CACACCTGAA TCTTATCCCT ACTACTACAA ATAGGGATGC 1560
TATTTTCTTG TCCTGTGTCC TGGATGGTGA ATTGAGTATC TTGTGCCCTG CCAAAAGCCA 1620
CTCTATGGCC ACCTCCTCTC TGTCCTAGGT TCCTGGAGGC TAACTGTGTA GCTCCCATCA 1680
ATGAGCGTCC TCTCTCTGGC TTTTAGTTAG GTATACTCTA CAGGCAGCCC CGGCAGGAAA 1740
TAAAAAGGTG GGAGGAGAGT GAGGTCATTT CTTCTGGCTT TCTCTTTGTG GAGTTACCAC 1800
AAGCTGACTG TGTCCCTTAT GAGAATAATC CAGCCCTCTC TAAACAATAT GGGTCTCTCC 1860
AGGTTCTGGT AGCCACTCTC CAGGTTCTGG TAGCCTTCCT TTGTCCATTC AGGCCCAAGG 1920
GGATGACATC TCCCCTGTTC CTAGTCTCCG CCTGTTACTA GTCTGTTATT AGTCTGGGGT 1980
ACCATATCCT TCTTGGAGTT TTCTTCAACC CTGTTCAATC CCTTTATTAA 2030
|
